ROLE OF DOOSHIVISHARI AGADA ON TERATOGENIC EFFECT OF CYFLUTHRIN IN EXPERIMENTAL MODEL W.S.R. FETAL WEIGHT AND HEIGHT
DOI:
https://doi.org/10.70066/jahm.v2i2.148Keywords:
Teratogenicity, Dooshivishari agada, Dooshivisha, GaravishaAbstract
Background: Pesticides are known for their toxicity on the mammalian system including embryonic development. Cyfluthrin (Trade name: Baygon and Solfac) is used commonly in India and reported to be a teratogenic agent and reported for low birth weight and stunned fetuses (short height), and dooshivishari agada (DVA) commonly use in conditions like garavishajanya dooshivisha. Aims: To evaluate the efficacy of dooshivishari Agada in cyfluthrin induced Teratogenicity with respect to body weight and height. Materials & Methods: The 30 pregnant swiss albino mice were divided in to 3 groups of 10 each and 1st group was control administered with normal saline, 2nd group given cyfluthrin 32mg/kg body wt, 3rd group cyfluthrin(32mg/kg body wt) With DVA 1.2gm/kg body wt orally during the organogenesis period i.e. from 5th to 14th day. Statistical analysis used: It was analyzed using student t test using software graph pad prism version 6. Results: There weights in 1st and 3rd groups are nearly equal and showed the increase of weight and height in3rd group i.e. treated group, weight: Group1-1.24±0.15, Group2-0.68±0.13, and group 3-1±0.11. Height: Group1-2.03±0.23, Group2-1.22±0.28, Group3-1.78±0.21 (Mean± SEM). Comparing the group 2 with group 3 the p value<0.05 in both the criteria’s. Conclusion: The dooshivishari agada has shown the significant effect in increasing the weight and height of the fetuses which were exposed to the teratogenic agent
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 SHILPA S. HUKKERI

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.